Davita Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? Davita Inc trades at $232 (market cap $15.12B), while Vanguard Total World Stock Index Fund ETF trades at $157.38. Which is the better fit depends on your goals.
| DVA | VT | |
|---|---|---|
Market Cap | $15.12B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $235.71 | $159.35 |
52-Week Low | $103.87 | $128.41 |
Enterprise Value | $27.67B | — |
Trailing returns across standard periods
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →